Sodium butyrate is a potent modulator of smooth muscle cell proliferation and gene expression

Cell Proliferation

Volumn 29, Issue 5, 1996, Pages 231-241

  Feng, P ^b   Ge, L ^c   Akyhani, N ^a   Liau, G ^a  

^a HOLLAND LABORATORY   (United States)

^b GLAXOSMITHKLINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; BUTYRIC ACID; BUTYRIC ACID DERIVATIVE; CYCLIC AMP; THROMBOSPONDIN;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; GENE EXPRESSION REGULATION; NONHUMAN; ONCOGENE C FOS; ONCOGENE C MYC; ONCOGENE K RAS; PHENOTYPE; RAT; SMOOTH MUSCLE FIBER;

ANIMALIA;

EID: 0029804478     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2184.1996.00998.x     Document Type: Article

References (41)

1. 2+ mobilization, by cyclic AMP and GMP in rabbit aortic smooth-muscle cells. Biochem. J. 288, 527.
2. BARONE MV, CROZAT A, TABAEE A, PHILIPSON L, RON D. (1994) CHOP (GADD153) and its oncogenic variant, TLS-CHOP, having opposing effects on the induction of G1/S arrest. Genes. Dev. 8, 453.
3. CASTLE VP, OU X, O'ROURKE K, DIXIT VM. (1993) High level thrombospondin 1 expression in two NIH 3T3 cloned lines confers serum- and anchorage-independent growth. J. Biol. Chem. 268, 2899.
4. CHAMLEY JH, CAMPBELL GR. (1975) Trophic influences of sympathetic nerves and cyclic AMP on differentiation and proliferation of isolated smooth muscle cells in culture. Cell Tissue Res. 161, 497.
5. DEFEUDIS FV. (1991) Coronary atherosclerosis: current therapeutic approaches and future trends. Life. Sci. 49, 689.
6. DEL SAL G, RUARO ME, PHILIPSON L, SCHNEIDER C. (1992) The growth arrest-specific gene, gas1, is involved in growth suppression. Cell 70, 595.
7. DESCHNER EE, RUPERTO JF, LUPTON JR, NEWMARK HL. (1990) Dietary butyrate (tributyrin) does not enhance AOM-induced colon tumorigenesis. Cancer Lett. 52, 79.
8. FENG P, LIAU G. (1993a) Identification of a novel serum and growth factor-inducible gene in vascular smooth muscle cells. J. Biol. Chem. 268, 9387.
9. FENG P, LIAU G. (1993b) Identification of a novel serum and growth factor-inducible gene in vascular smooth muscle cells. J. Biol. Chem. 268, 21 453.
10. FREGEAU C, HELGASON CB, BLEACKLEY RC. (1992) Two cytotoxic cell proteinase genes are differentially sensitive to sodium butyrate. Nucleic Acids Res. 20, 3113.
11. GE L, LIAU G. (1995) Isolation of a cDNA encoding a growth-arrest associated gene and characterization of its regulation. J. Cell. Biochem. 57, 331.
12. GLAUBER JG, WANDERSEE NJ, LITTLE JA, GINDER GD. (1991) 5′-Flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cells. Mol. Cell. Biol. 11, 4690.
13. GREISLER HP, CZIPERLE DJ, KIM DU et al. (1992) Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor type 1 pretreatment. Surgery 112, 244.
14. HERUTH DP, ZIRNSTEIN GW, BRADLEY JF, ROTHBERG PG. (1993) Sodium butyrate causes an increase in the block to transcriptional elongation in the c-myc gene in SW837 rectal carcinoma cells. J. Biol. Chem. 268, 20 466.
15. JANAT MF, LIAU G. (1992) Transforming growth factor beta-1 is a powerful modulator of platelet-derived growth factor action in vascular smooth muscle cells. J. Cell. Physiol. 150, 232.
16. JONZON B, NILSSON J, FREDHOLM BB. (1985) Adenosine receptor-mediated changes in cyclic AMP production and DNA synthesis in cultured arterial smooth muscle cells. J. Cell. Physiol. 124, 451.
17. KRUH J. (1982) Effect of sodium butyrate, a new pharmacological agent, on cells in culture. Mol. Cell Biochem. 42, 65.
18. KRYITSIS AP, TSOKOS M, CHADER GJ. (1986) Control of retinoblastoma cell growth by differentiating agents: Current work and future directions. Anticancer Res. 6, 465.
19. LAU LF, NATHANS D. (1991) Genes induced by serum growth factors. In: Cohen P, Foulkes JG, eds. The Hormonal Control Regulation of Gene Transcription. Cambridge: Elsevier Science, 257.
20. LEDER A, LEDER P. (1975) Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell 5, 319.
21. LIAU G, CHAN LM. (1989) Regulation of extracellular matrix RNA levels in cultured smooth muscle cells: Relationship to cellular quiescence. J. Biol. Chem. 264, 10 315.
22. LIAU G, CHAN LM, FENG P. (1991) Increased ferritin gene expression is both promoted by cAMP and a marker of growth arrest in rabbit vascular smooth muscle cells. J. Biol. Chem. 266, 18 819.
23. LIAU G, YAMADA Y, DECROMBRUGGHE B. (1985) Coordinate regulation of the levels of type IV and type I collagen mRNA in most but not all mouse fibroblasts. J. Biol. Chem. 260, 531.
24. MACPHEE M, NUNEZ H, HENNINGS R et al. (1996) Fibrin sealant: A versatile delivery vehicle for drugs and biologies. In: Saltz R, Sierra D, eds. Current Trends in Surgical Tissue Adhesives. PA: Technomic Publishers, 109.
25. MAJACK RA. (1987) Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J. Cell Biol. 105, 465.
26. MAJACK RA, GOODMAN LV, DIXIT VM. (1988) Cell surface thromobospondin is functionally essential for vascular smooth muscle cell proliferation. J. Cell Biol. 106, 415.
27. MAJACK RA, MILDBRANDT J, DIXIT VM. (1987) Induction of thrombospondin messenger RNA levels occurs as an immediate primary response to platelet-derived growth factor. J. Biol. Chem. 262, 8821.
28. MILLER AA, KURSCHEL E, OSIEKA R, SCHMIDT CG. (1987) Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur. J. Cancer Clin. Oncol. 28, 1283.
29. MORROW CS, NAKAGAWA M, GOLDSMITH ME, MADDEN MJ, COWAN KH. (1994) Reversible transcriptional activation of mdr1 by sodium butyrate treatment of human colon cancer cells. J. Biol. Chem. 269, 10 739.
30. NISHINA Y, SUMI T, IWAI SA, KOSAKA M, NISHIMUNE Y. (1993) The induction of jun genes during the reversible changes induced with sodium butyrate on the differentiation of F9 cells. Exp. Cell Res. 208, 492.
31. NOVOGRODSKY A, DVIR A, RAVID A et al. (1983) Effect of polar organic compounds on leukemic cells. Butyrate-induced partial remission of acute myelogemous leukemia in a child. Cancer 51, 9.
32. NUDELMAN A, RUSE M, AVIRAM A et al. (1992) Novel anticancer prodrugs of butyric acid. J. Med. Chem. 35, 687.
33. PERRINE SP, GINDER GD, FALLER DV et al. (1993) A short-term trial of butyrate to stimulate fetal-globin-gene expression in the β-globin disorders. N. Engl. J. Med. 328, 81.
34. PLESKO MM, HARGROVE JL, GRANNER DK, CHALKLEY R. (1983) Inhibition by sodium butyrate of enzyme induction by glucocorticoids and dibutyrylcyclic AMP: A role for the rapid form of histone acetylation. J. Biol. Chem. 258, 13 738.
35. POPMA JJ, CALIFF RM, TOPOL EJ. (1991) Clinical trials of restenosis after coronary angioplasty. Circulation 84, 1426.
36. POUILLART P, CERUTTI I, RONCO G, VILLA P, CHANG C. (1991) Butyric monosaccharide ester-induced cell differentiation and anti-tumor activity in mice. Importance of their prolonged biological effect for clinical applications in cancer therapy. Int. J. Cancer 49, 89.
37. PRASAD KN. (1980) Butyric acid: A small fatty acid with diverse biological function. Life Sci. 27, 1351.
38. RAYMONDJEAN M, TICHONICK L, KRUH J. (1985) Effect of sodium butyrate on the complexity and the translation activity of hepatoma tissue-cultured cell RNAs. Biol. Cell 54, 39.
39. ROSS R. (1993) The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362, 801.
40. WAKSELMAN M, CERUTTI I, CHANG C. (1990) Anti-tumor protection induced in mice by fatty acid conjugates: Alkyl butyrates and poly(ethylene glycol) dibutyrates. Int. J. Cancer 46, 462.
41. ZHAN Q, LORD KA, ALAMO IJ et al. (1994) The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol. Cell. Biol. 14, 2361.